Last reviewed · How we verify
NCT03333785
Randomized Trial of eOncoNote
NA trial testing eOncoNote in Communication Research in 181 participants. Completed in 17 February 2021.
31 August 2020
Quick facts
| Lead sponsor | University of Toronto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 181 |
| Start date | 5 February 2018 |
| Primary completion | 31 August 2020 |
| Estimated completion | 17 February 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- eOncoNote
Conditions studied
- Communication Research — all drugs for Communication Research →
- Breast Cancer — all drugs for Breast Cancer →
- Prostate Cancer — all drugs for Prostate Cancer →
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
University of Toronto
Who can join
18 and older, any sex, with Communication Research or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Improving Cancer Care Together through eOncoNote is a pragmatic randomized trial involving a secure online eConsultation system (referred to as eOncoNote) that will allow primary care providers and cancer specialist providers to communicate about their patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial.
Petrovic B, Julian JA, Liddy C, Afkham A, et al · · 2023 · cited 5× · PMID 36652284 · DOI 10.2196/40725
Verify or expand the search:
- PubMed search for NCT03333785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Communication Research
Currently open trials in the same condition.
- NCT07127887 — Language Translation of Knowledge Mobilization Resources · NA · recruiting
- NCT06417762 — Dime La VerDAD: Verify, Debunk, and Disseminate · NA · recruiting
- NCT05979090 — Mastery Learning in Communication Skills · NA · recruiting
- NCT05356962 — STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room · NA · recruiting
- NCT04985903 — Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women · NA · recruiting
Other University of Toronto trials
Trials by the same sponsor.
- NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03333785 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Toronto
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03333785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing